Issues of migration potential and plasticity of different types of stem cells continue to arouse considerable interest among researchers in terms of improving the regenerative properties of cell and tissue transplantation [1] . First of all study in this area concerned the scope of bone marrow transplantation, which has been used in clinics for a long time [2, 3] . The ability of hematopoietic cell migration between niches and their transdifferentiation into other germ layer derivatives are the subject of scientific discussions.
Mechanisms of attracting hematopoietic stem cells in the repair of damaged nerve tissue are of particular interest. According to animal experiments and results of the retrospective analysis of some clinical studies of bone marrow recipients there has been demonstrated not only the presence of donor cells in areas of brain damage, but their expression of a number of markers characteristic for neurons and glia [4] [5] [6] [7] [8] . These studies suggest that transplanted cells come from blood flow to ischemic areas and differentiate into neural cells. However, there are researches with opposite results that cast doubt on these findings. Although the possibility of fusion of donor cells with recipient cells also remains relevant [9] .
Therefore, many factors should be taken into account, including the source, methods of cell's obtaining, preparation and method of transplantation. In particular, the source of stem cells may influence on their maturity and, therefore, the potential for migration and differentiation. The presence of multipotent mesenchymal stromal cells fraction among transplanted bone marrow mononuclear cells does not allow to prove the ability of hematopoietic cells to transdifferentiation.
To characterize hematopoietic stem cells in mice there have been developed a group of immunophenotypic attribute that allow identification of LSK-cells populations expressing stem cell antigen Sca-1 and stem cell growth factor receptor c-kit, with no expression of linearity Lin markers
SUMMARY
The study of migration and differentiation potential of different types of stem cells remains a problem for cell biology and regenerative medicine. The purpose of the study was to evaluate the ability of transplanted hematopoietic stem cells (HSC) of murine fetal liver to migrate into a zone of hippocampal ischemic injury at suboccipital intraventricular injection; and to assess their neural differentiation possibility in the early period after transplantation.
MATERIALS AND METHODS.
We modeled an ischemic injury of the hippocampus of FVB-wt mice and after 24 hours transplanted suboccipitaly fetal liver HSC of FVB-Cg-Tg(GFPU)5Nagy/J fetuses (transgenic by GFP An ischemic stroke developed after an external 20-minute occlusion of carotid arteries in the control group animals without cell transplantation, the maximum changes were observed in the hippocampal CA1 region. On the 8th day after the modeling a characteristic feature of ischemic hippocampus was reducing of pyramidal neurons number up to 70 % with their degeneration and reactive astrogliosis.
On the 7 th day after transplantation in the animals injected with fetal liver HSC, donor cells were found at the site of injection in the walls of the 3 rd brain ventricle. The cells localized in the tissue at a depth of 10 μm and kept a rounded shape. (Fig. 1) In some brain slices we identified a group of cells that were in the tissue at different depths up to 100 μm from the ventricle wall, which may indicate an active migration of transplanted cells to the direction of ischemized zone, reached of injured hippocampus (Fig. 2) .
On the 14 th day single transplanted cells, maintaining a rounded shape without morphological signs of differentiation, were detected in the hippocampal CA1 region. But donor cells were not found in other analyzed brain structures (data are not shown).
Thus, on the 7 th and the 14 th day after cell transplantation (8th and 15th day after the modeling of ischemic brain injury, respectively), experimental animals kept signs of reactive astrogliosis and loss of neurons in hippocampal CA1 region, similar to parameters in the control group.
At immunohistochemical study on the 7 th and the 14 th day after injection transplanted cells did not express neuronal marker NeuN and astrocytes marker GFAP, confirming and supplementing the other authors' data. The relative content of viable cells, which was determined using of 7-aminoactinomycin D (7-AAD), after sorting was 88.5 ± 3.8 %.
Ischemic stroke in FVB-wt mice (n = 4) was modeled by a 20-minute occlusion of both common carotid arteries. Before operation and cells transplantation the mice were anesthetized via intraperitoneal administration of Calypsol (75 mg/kg) and Xylazine (2 mg/kg). In 24 hours after hippocampal ischemia 2·10 5 selected HSC in 20 μl DMEM+F12 (Sigma, USA) were transplanted into 3 rd ventricle of the brain through suboccipitial region. Control group include animals with simulated ischemic brain damage, which were administered with only 20 μl DMEM+F12 medium (n = 2), and pseudooperated animals (n = 2).
Immunohistochemical study of the brain was performed at the Department of Cytology of Bogomoletz Institute of Physiology NAS Ukraine. In 7 or 14 days after transplantation, mice were anesthetized intraperitoneally (75 mg/kg Calypsol) and by inhalation of ether. not detect their expression of NeuN and calbindin (markers specific to Purkinje cells), and even Iba1 [12] . Wehner T. et al. also found that bone marrow cells, transplanted into mice with focal cerebral ischemia, do not differentiate into astrocytes [13] .
Although our study did not reveal signs of morphological improvement in hippocampal ischemic areas as well as changes of morphology and phenotype of donor cells, the fact of transplanted hematopoietic cells migration from the ventricular cavity into the area of ischemic brain damage confirms the assumption of many researchers that donor stem cells of different types, including hematopoietic, are able to respond to signals of ischemic tissue and actively migrate to the area of injury [14, 15] . 
